Zealand Pharma A/s (22Z) traded at 33.26 € on November 11, 2026. 1 of 1 sharewise users currently rate it a buy.
Key Points Interested in Village Farms International, Inc.? Here are five stocks we like better. Village Farms is targeting international cannabis growth through its EU GMP-certified Delta
Key Points Interested in Sensus Healthcare, Inc.? Here are five stocks we like better. Second-quarter revenue fell sharply to $2.3 million from $7.3 million a year earlier, primarily because
Key Points Interested in Merlin, Inc. Common Stock? Here are five stocks we like better. Second-quarter revenue rose to approximately $2.2 million, up $1.2 million sequentially, while Merlin
| Security | YTD | 3y |
|---|---|---|
| Zealand Pharma A/s | -47.92% | -11.95% |
| NanoViricides Inc. | 25.81% | 21.88% |
| Ocuphire Pharma Inc. | 127.11% | 43.61% |
| Saniona AB | -45.57% | 147.98% |
